Table 3 |
|||
|
Response to treatment |
|||
|
Clinical response (RECIST) N = 29 No. (%) |
Biochemical response (Chromogranin A) N = 25 No. (%) |
Symptomatic response N = 15 No. (%) |
|
|
|
|||
|
Progression |
2 (6.9) |
2 (8.0) |
|
|
No change |
20 (69.0) |
11 (44.0) |
6 (40.0) |
|
Partial response |
7 (24.1) |
8 (32.0) |
6 (40.0) |
|
Complete response |
- |
4 (16.0) |
3 (20.0) |
|
Overall response |
7 (24.1) (95% CI 8.3-39.9) |
12 (48.0) (95% CI 28.0-68.0) |
9 (60.0) |
|
|
|||
|
RECIST = Response Evaluation Criteria in Solid Tumors |
|||
|
Brizzi et al. BMC Cancer 2009 9:388 doi:10.1186/1471-2407-9-388 |
|||